RhumbLine Advisers’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,123
| Closed | -$134K | – | 3172 |
|
|
2021
Q1 | $134K | Buy |
5,123
+51
| +1% | +$1.33K | ﹤0.01% | 2905 |
|
|
2020
Q4 | $183K | Buy |
5,072
+534
| +12% | +$19.3K | ﹤0.01% | 2865 |
|
|
2020
Q3 | $161K | Buy |
4,538
+65
| +1% | +$2.31K | ﹤0.01% | 2751 |
|
|
2020
Q2 | $190K | Buy |
4,473
+3,749
| +518% | +$159K | ﹤0.01% | 2788 |
|
|
2020
Q1 | $58K | Hold |
724
| – | – | ﹤0.01% | 2850 |
|
|
2019
Q4 | $67K | Buy |
724
+9
| +1% | +$833 | ﹤0.01% | 2905 |
|
|
2019
Q3 | $54K | Buy |
715
+8
| +1% | +$604 | ﹤0.01% | 2921 |
|
|
2019
Q2 | $70K | Buy |
+707
| New | +$70K | ﹤0.01% | 2948 |
|